<HTML>


<HEAD>








<TITLE>Begin Typing Here</TITLE>


<META NAME="doccomm" CONTENT="Email Prep macro was completed 04/21/2005 13:15">


<META NAME="Template" CONTENT="C:\Program Files\MacPac\MacPac90\Templates\Business.dot">


</HEAD>


<BODY>





<FONT SIZE=2>


<B><P ALIGN="CENTER">UNITED STATES</P>


<P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>


<P ALIGN="CENTER">Washington, D.C. 20549</P>


</FONT><FONT SIZE=5><P ALIGN="CENTER">FORM 8-K</P>


</B></FONT><FONT SIZE=2>


<B><P ALIGN="CENTER">CURRENT REPORT</P>


<P ALIGN="CENTER">Pursuant to Section 13 or 15(d) of </P>


<P ALIGN="CENTER">the Securities Exchange Act of 1934</P>


</B>


<P ALIGN="CENTER">Date of Report (Date of earliest event reported):  <B>June 17, 2005</P>


</B>


<P>&nbsp;</P></FONT>


<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=9 WIDTH=720>


<TR><TD VALIGN="TOP" COLSPAN=3>


<B><FONT SIZE=2><P ALIGN="CENTER">CORGENTECH INC.</B></FONT></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3>


<FONT SIZE=2><P ALIGN="CENTER">(Exact name of registrant as specified in its charter)</FONT></TD>


</TR>


<TR><TD WIDTH="33%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="33%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="33%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="33%" VALIGN="TOP">


<B><FONT SIZE=2><P ALIGN="CENTER">Delaware</B></FONT></TD>


<TD WIDTH="33%" VALIGN="TOP">


<B><FONT SIZE=2><P ALIGN="CENTER">000-50573</B></FONT></TD>


<TD WIDTH="33%" VALIGN="TOP">


<B><FONT SIZE=2><P ALIGN="CENTER">77-0503399</B></FONT></TD>


</TR>


<TR><TD WIDTH="33%" VALIGN="TOP"><DIR>





<FONT SIZE=2><P ALIGN="CENTER">(State or other jurisdiction</DIR>


</FONT></TD>


<TD WIDTH="33%" VALIGN="TOP">


<FONT SIZE=2><P ALIGN="CENTER">(Commission</FONT></TD>


<TD WIDTH="33%" VALIGN="TOP">


<FONT SIZE=2><P ALIGN="CENTER">(IRS Employer</FONT></TD>


</TR>


<TR><TD WIDTH="33%" VALIGN="TOP"><DIR>





<FONT SIZE=2><P ALIGN="CENTER">of incorporation)</DIR>


</FONT></TD>


<TD WIDTH="33%" VALIGN="TOP">


<FONT SIZE=2><P ALIGN="CENTER">File Number)</FONT></TD>


<TD WIDTH="33%" VALIGN="TOP">


<FONT SIZE=2><P ALIGN="CENTER">Identification No.)</FONT></TD>


</TR>


<TR><TD WIDTH="67%" VALIGN="TOP" COLSPAN=2>&nbsp;</TD>


<TD WIDTH="33%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="67%" VALIGN="TOP" COLSPAN=2>&nbsp;</TD>


<TD WIDTH="33%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3>


<B><FONT SIZE=2><P ALIGN="CENTER">650 Gateway Boulevard</P>


<P ALIGN="CENTER">South San Francisco, California 94080</B></FONT></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=19>


<FONT SIZE=2><P ALIGN="CENTER">(Address of principal executive offices and Zip Code)</FONT></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=19><P></P></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=19><P></P></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=19>


<FONT SIZE=2><P ALIGN="CENTER">Registrant's telephone number, including area code: <B>(650) 624-9600</B></FONT></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=19><P></P></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=19><P></P></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=19>


<B><FONT SIZE=2><P ALIGN="CENTER">Not applicable</B></FONT></TD>


</TR>


<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=19>


<FONT SIZE=2><P ALIGN="CENTER">(Former name or former address, if changed since last report.)</FONT></TD>


</TR>


</TABLE>


</CENTER></P>





<FONT SIZE=2><P>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>


<P>[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>


<P>[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>


<P>[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>


<P>[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>


<B>


<P>Item 1.02 Termination of a Material Definitive Agreement. </P>


</B>


<P>On June 17, 2005, Corgentech Inc. terminated for no cause its Licensing Agreement, dated September 27, 2004, with Cyclacel Limited, or Cyclacel, pursuant to Section 11.3 of the Licensing Agreement. The Licensing Agreement is filed as Exhibit 10.33 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004. In September 2004, Corgentech paid Cyclacel an up-front fee and licensed a novel peptide delivery system from Cyclacel for potential use to assist in the systemic delivery of TF Decoys.&nbsp; The license granted Corgentech use of Cyclacel's proprietary Penetratin delivery technology with TF Decoys.&nbsp; There was no payment by Cyclacel or Corgentech in connection with the termination of the Licensing Agreement.</P>





<B><P><A NAME="Item9_01FinancialStatementsAndExh_073616">Item 9.01 Financial Statements and Exhibits</A></P>


</B><P>&nbsp;</P><DIR>


<DIR>





<P>(c)</FONT><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT SIZE=2>Exhibits</P></DIR>


</DIR>





<P>&nbsp;</P></FONT>


<TABLE BORDER CELLSPACING=2 WIDTH=720>


<TR><TD WIDTH="8%" VALIGN="TOP">


<B><FONT SIZE=1><P>Exhibit<BR>


Number</B></FONT></TD>


<TD WIDTH="2%" VALIGN="BOTTOM">


<B><FONT SIZE=1><P ALIGN="CENTER">&nbsp;</B></FONT></TD>


<TD WIDTH="90%" VALIGN="BOTTOM">


<B><FONT SIZE=1><P ALIGN="CENTER">Description</B></FONT></TD>


</TR>


<TR><TD WIDTH="8%" VALIGN="TOP">


<FONT SIZE=2><P>10.43</FONT></TD>


<TD WIDTH="2%" VALIGN="BOTTOM">


<FONT SIZE=2><P>&nbsp;</FONT></TD>


<TD WIDTH="90%" VALIGN="TOP">


<FONT SIZE=2><P>Notice of Termination Letter, dated June 17, 2005, to Licensing Agreement, dated September 27, 2004, with Cyclacel Limited.</FONT></TD>


</TR>


<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="2%" VALIGN="BOTTOM">&nbsp;</TD>


<TD WIDTH="90%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="2%" VALIGN="BOTTOM">&nbsp;</TD>


<TD WIDTH="90%" VALIGN="TOP">&nbsp;</TD>


</TR>


</TABLE>








<FONT SIZE=2><P ALIGN="CENTER">&nbsp;</P><DIR>


<DIR>


<DIR>


<DIR>





<B><P ALIGN="CENTER">SIGNATURES</P></DIR>


</DIR>


</DIR>


</DIR>





</B><P ALIGN="JUSTIFY">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P></FONT>


<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=727>


<TR><TD WIDTH="50%" VALIGN="TOP">


<FONT SIZE=2><P>Date:  June 23, 2005</P>


</FONT></TD>


<TD WIDTH="50%" VALIGN="TOP">


<B><FONT SIZE=2><P>Corgentech Inc.</P>


</B>


<P>By: <U>&#9;/s/ Richard P. Powers&#9;</P>


</U><P>&#9;Richard P. Powers</P>


<P>&#9;Vice President and Chief Financial Officer</FONT></TD>


</TR>


<TR><TD WIDTH="50%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="50%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="50%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="50%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="50%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="50%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="50%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="50%" VALIGN="TOP">&nbsp;</TD>


</TR>


</TABLE>





<FONT SIZE=2><P ALIGN="JUSTIFY"></P>


<P ALIGN="CENTER">&nbsp;</P>


<B><P ALIGN="CENTER"><A NAME="ExhibitIndex">EXHIBIT INDEX</A></P>


</B></FONT>


<TABLE BORDER CELLSPACING=2 WIDTH=720>


<TR><TD WIDTH="8%" VALIGN="TOP">


<B><FONT SIZE=1><P>Exhibit<BR>


Number</B></FONT></TD>


<TD WIDTH="2%" VALIGN="BOTTOM">


<B><FONT SIZE=1><P ALIGN="CENTER">&nbsp;</B></FONT></TD>


<TD WIDTH="90%" VALIGN="BOTTOM">


<B><FONT SIZE=1><P ALIGN="CENTER">Description</B></FONT></TD>


</TR>


<TR><TD WIDTH="8%" VALIGN="TOP">


<FONT SIZE=2><P>10.43</FONT></TD>


<TD WIDTH="2%" VALIGN="BOTTOM">


<FONT SIZE=2><P>&nbsp;</FONT></TD>


<TD WIDTH="90%" VALIGN="TOP">


<FONT SIZE=2><P>Notice of Termination Letter, dated June 17, 2005, to Licensing Agreement, dated September 27, 2004, with Cyclacel Limited.</FONT></TD>


</TR>


<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="2%" VALIGN="BOTTOM">&nbsp;</TD>


<TD WIDTH="90%" VALIGN="TOP">&nbsp;</TD>


</TR>


<TR><TD WIDTH="8%" VALIGN="TOP">&nbsp;</TD>


<TD WIDTH="2%" VALIGN="BOTTOM">&nbsp;</TD>


<TD WIDTH="90%" VALIGN="TOP">&nbsp;</TD>


</TR>


</TABLE>





<P ALIGN="RIGHT"></P></BODY>


</HTML>
[{"type": "8-K", "sequence": "1", "filename": "rrd83455.htm", "description": "FORM 8-K", "secsgml_size_bytes": 8556}]
{"company-data": {"conformed-name": "CORGENTECH INC", "cik": "0001131517", "assigned-sic": "2834", "irs-number": "770503399", "state-of-incorporation": "DE"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-50573", "film-number": "05912117"}, "business-address": {"street1": "650 GATEWAY BOULEVARD", "street2": "--", "city": "SOUTH SAN FRANCISCO", "state": "CA", "zip": "94080", "phone": "6506249600"}, "mail-address": {"street1": "650 GATEWAY BOULEVARD", "city": "SOUTH SAN FRANCISCO", "state": "CA", "zip": "94080"}}
Begin Typing Here
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 17, 2005
CORGENTECH INC.
(Exact name of registrant as specified in its charter)
Delaware
000-50573
77-0503399
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
650 Gateway Boulevard
South San Francisco, California 94080
(Address of principal executive offices and Zip Code)
Registrant's telephone number, including area code:
(650) 624-9600
Not applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.02 Termination of a Material Definitive Agreement.
On June 17, 2005, Corgentech Inc. terminated for no cause its Licensing Agreement, dated September 27, 2004, with Cyclacel Limited, or Cyclacel, pursuant to Section 11.3 of the Licensing Agreement. The Licensing Agreement is filed as Exhibit 10.33 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004. In September 2004, Corgentech paid Cyclacel an up-front fee and licensed a novel peptide delivery system from Cyclacel for potential use to assist in the systemic delivery of TF Decoys.  The license granted Corgentech use of Cyclacel's proprietary Penetratin delivery technology with TF Decoys.  There was no payment by Cyclacel or Corgentech in connection with the termination of the Licensing Agreement.
Item 9.01 Financial Statements and Exhibits
(c)
Exhibits
Exhibit
Number
Description
10.43
Notice of Termination Letter, dated June 17, 2005, to Licensing Agreement, dated September 27, 2004, with Cyclacel Limited.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:  June 23, 2005
Corgentech Inc.
By:
/s/ Richard P. Powers
Richard P. Powers
Vice President and Chief Financial Officer
EXHIBIT INDEX
Exhibit
Number
Description
10.43
Notice of Termination Letter, dated June 17, 2005, to Licensing Agreement, dated September 27, 2004, with Cyclacel Limited.